Viatris Inc (NASDAQ:VTRS)
| 9.63 BATS BZX Real-Time Price As of 2:31pm ET |  +0.07 / +0.73%Today’s Change | 8.42 Today|||52-Week Range 12.40 | -13.52% Year-to-Date |
Latest VTRS News | Press Releases
| Which Is the Better Dividend Stock: Viatris or Apple? 8:00am / MotleyFool.com - Paid Partner Content | Use These 3 Strategies to Make $1,000 in Passive Income Per Year Mar 23 / MotleyFool.com - Paid Partner Content |
| Why Is Viatris (VTRS) Down 16.4% Since Last Earnings Report? Mar 29 / Zacks.com - Paid Partner Content | Is Viatris' 5% Dividend Yield Safe? Mar 21 / MotleyFool.com - Paid Partner Content |
| 3 Healthcare Spinoffs Worth a Look, But 1 Has the Best Long-Term Potential Mar 26 / MotleyFool.com - Paid Partner Content | Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? Mar 20 / Zacks.com - Paid Partner Content |
| I Own 12 High-Yield Dividend Stocks. Here's the Best of the Bunch. Mar 25 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 9.56 |
| Today’s open | 9.66 |
| Day’s range | 9.60 - 9.70 |
| Volume | 137,482 |
| Average volume (3 months) | 8,979,547 |
| Market cap | $11.2B |
Data as of 2:31pm ET, 03/31/2023
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -12.55% |
| Earnings growth (next 5 years) | -1.60% |
| Revenue growth (last year) | -9.42% |
| P/E ratio | 5.6 |
| Price/Sales | 0.84 |
| Price/Book | 0.54 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CTLTCatalent Inc | +1.20 | +1.86% |
| ---- | ||
| SRPTSarepta Therapeutics... | +2.54 | +1.87% |
| ---- |
Data as of 2:33pm ET, 03/31/2023
Financials
| Next reporting date | May 8, 2023 |
| EPS forecast (this quarter) | $0.70 |
| Annual revenue (last year) | $16.2B |
| Annual profit (last year) | $2.1B |
| Net profit margin | 12.85% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Canonsburg, Pennsylvania |
Forecasts
